Age-related macular degeneration (AMD) is the most common cause of vision loss in people over the age of 65 in developed countries. In most patients, a "dry" form of AMD is noted, which gradually progresses.
Choroidal nonvascular membrane is the main sign of "wet" form of AMD which is present in 10 % of patients approximately. AMD develops as a result of an interaction between genetic and lifestyle factors of patients.
The treatment of the choice of the wet form of AMD is intravitreal anti-VEGF injections, in the case of the dry form of AMD we can choose antioxidants, preparations with lutein and haemorheopheresis. An essential prerequisite for successful treatment is early diagnosis and especially early initiation of the treatment